I agree that this site is using cookies. You can find further informations here.
X
Nakakariya, Masanori
28  results:
Search for persons X
?
1

Effects of an OX2R agonist on migration and removal of tau ..:

Terada, Michiko ; Mitsukawa, Kayo ; Nakakariya, Masanori..
Scientific Reports.  14 (2024)  1 - p. , 2024
Link: https://doi.org/10.1038/..
 
?
2

Orexin receptor 2 agonist activates diaphragm and genioglos..:

Yamada, Ryuji ; Koike, Tatsuki ; Nakakariya, Masanori..
PLOS ONE.  19 (2024)  6 - p. e0306099 , 2024
Link: https://doi.org/10.1371/..
 
?
3

DNA/RNA heteroduplex technology with cationic oligopeptide ..:

Ohara, Masahiro ; Nagata, Tetsuya ; Hara, Rintaro Iwata...
Molecular Therapy - Nucleic Acids.  , 2024
Link: https://doi.org/10.1016/..
 
?
4

Interlaboratory Variability in the Madin–Darby Canine Kidne..:

Harwood, Matthew D. ; Zettl, Katharina ; Weinheimer, Manuel...
Molecular Pharmaceutics.  20 (2023)  7 - p. 3505-3518 , 2023
Link: https://doi.org/10.1021/..
 
?
5

Novel insights in drug transporter sciences: the year 2021 ..:

Chothe, Paresh P. ; Mitra, Pallabi ; Nakakariya, Masanori...
Drug Metabolism Reviews.  54 (2022)  3 - p. 299-317 , 2022
Link: https://doi.org/10.1080/..
 
?
6

Inhibition of MGAT2 modulates fat‐induced gut peptide relea..:

Mochida, Taisuke ; Take, Kazumi ; Maki, Toshiyuki...
FEBS Open Bio.  10 (2020)  3 - p. 316-326 , 2020
Link: https://doi.org/10.1002/..
 
?
7

Discovery of 1,8-naphthyridin-2-one derivative as a potent ..:

Yukawa, Takafumi ; Nakahata, Takashi ; Okamoto, Rei...
Bioorganic & Medicinal Chemistry.  28 (2020)  7 - p. 115376 , 2020
Link: https://doi.org/10.1016/..
 
?
8

Physiologically‐Based Pharmacokinetic Models for Evaluating..:

Taskar, Kunal S. ; Pilla Reddy, Venkatesh ; Burt, Howard...
Clinical Pharmacology & Therapeutics.  107 (2019)  5 - p. 1082-1115 , 2019
Link: https://doi.org/10.1002/..
 
?
9

Established chemical knockout condition for P-GP mediated e..:

Nakakariya, Masanori ; Yang, Li ; Chen, Ron..
Drug Metabolism and Pharmacokinetics.  34 (2019)  1 - p. S76 , 2019
Link: https://doi.org/10.1016/..
 
?
10

Time-dependent inhibition of drug transporters:

Yucha, Robert ; Chuang, Bei-Ching ; Fukushi, Chiharu...
Drug Metabolism and Pharmacokinetics.  33 (2018)  1 - p. S92-S93 , 2018
Link: https://doi.org/10.1016/..
 
?
11

Discovery of 7-Oxo-2,4,5,7-tetrahydro-6H-pyrazolo[3,4-c]pyr..:

Yoshikawa, Masato ; Saitoh, Morihisa ; Katoh, Taisuke...
Journal of Medicinal Chemistry.  61 (2018)  6 - p. 2384-2409 , 2018
Link: https://doi.org/10.1021/..
 
?
12

CETSA quantitatively verifies in vivo target engagement of ..:

Ishii, Tsuyoshi ; Okai, Takuro ; Iwatani-Yoshihara, Misa...
Scientific Reports.  7 (2017)  1 - p. , 2017
Link: https://doi.org/10.1038/..
 
?
13

Bombesin receptor subtype‐3‐expressing neurons regulate ene..:

Maruyama, Minoru ; Hotta, Natsu ; Nio, Yasunori...
Brain and Behavior.  8 (2017)  1 - p. , 2017
Link: https://doi.org/10.1002/..
 
?
14

A Selective Bombesin Receptor Subtype 3 Agonist Promotes We..:

Nio, Yasunori ; Hotta, Natsu ; Maruyama, Minoru...
Endocrinology.  158 (2017)  5 - p. 1298-1313 , 2017
Link: https://doi.org/10.1210/..
 
?
15

Appropriate risk criteria for OATP inhibition at the drug d..:

Nakakariya, Masanori ; Goto, Akihiko ; Amano, Nobuyuki
Drug Metabolism and Pharmacokinetics.  31 (2016)  5 - p. 333-339 , 2016
Link: https://doi.org/10.1016/..
 
1-15